tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dina Ramadane, 3 are a BUY (100%).
Analyst Dina Ramadane, currently employed at BAML, carries an average stock price target met ratio of 33.33% that have a potential upside of 57.33% achieved within 57 days.
Dina Ramadane’s has documented 6 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on VERA, Vera Therapeutics at 07-Jul-2026.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 10/16/2025. The price target of $48 was fulfilled within 57 days with a profit of $17.49 (57.33%) receiving and performance score of 10.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Nov-2024
$43
$4.5 (11.69%)
$23
11 days ago
(08-Jul-2026)
7/7 (100%)
$0.57 (1.34%)
125
Buy Since 05-May-2025
$125
$86.5 (224.68%)
$110
11 days ago
(08-Jul-2026)
0/7 (0%)
$82.57 (194.60%)
Buy Since 07-Oct-2024
$78
$39.5 (102.60%)
$73
11 days ago
(08-Jul-2026)
0/3 (0%)
$35.57 (83.83%)
Buy Since 16-Aug-2023
$76
$37.5 (97.40%)
$61
11 days ago
(08-Jul-2026)
1/6 (16.67%)
$33.57 (79.12%)
164
Buy Since 16-Oct-2025
$70
$31.5 (81.82%)
$66
12 days ago
(07-Jul-2026)
1/3 (33.33%)
$27.04 (62.94%)
57
Which stock is Dina Ramadane is most bullish on?
What Year was the first public recommendation made by Dina Ramadane?
